Autism is linked to a fourfold increased risk for early-onset Parkinson’s disease, results from the largest, population-based ...

Key Takeaways Dr. Robert Jarvik created the first artificial heart used in humansHe's died from complications of Parkinson’s ...

People diagnosed with obstructive sleep apnea may face more than just poor sleep and tired mornings. A new study finds they ...

Biohaven has started a randomised Phase II/III trial of the TYK2 / JAK1 inhibitor, BHV-8000, aimed at treating early ...

A new study reveals that individuals with autism are four times more likely to develop early-onset Parkinson’s disease highlighting shared dopamine-related pathways ...

With every 100 grams of ultra-processed foods you consume each day, your risk of developing cardiovascular disease, ...

Iowa state Sen. Art Staed, a Democrat from Cedar Rapids, said he plans to continue to serve in the Iowa Senate in light of ...

"It's not a life-threatening disease, but I'd like to say it's a life-altering disease,"Parkinson's disease advocate Elle Blankenship said.She's just 14 years o ...

Sir Billy Connolly has been a fixture on the comedy scene for more than five decades but he has stepped back from the ...

Ozzy Osbourne has opened up about his health amid his final Black Sabbath performance this summer. The rockstar is set to ...

The legendary rocker, 76, will take to the stage on July 5, as he performs with Black Sabbath in his native Birmingham at Villa Park for his Back to the Beginning show.

INBRIJA, a dopamine replacement therapy for off periods in Parkinson's disease, holds significant market potential due to its ability to provide rapid relief from motor symptoms. With the increasing ...